Capstone Investment Advisors
BDSX icon

Capstone Investment Advisors’s Biodesix BDSX Stock Holding History

Capstone Investment Advisors’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-772
Closed -$9.65K – 1578
2025
Q1 		$9.65K Buy
+772
New +$14.8K ﹤0.01% 1316

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Capstone Investment Advisors's BDSX Position: Q2 2025 in Review

Capstone Investment Advisors sold out of Biodesix (BDSX) in Q2 2025, closing a stake of 772 shares — an estimated $9.65K sold.

Capstone Investment Advisors first reported a position in BDSX in Q1 2025 and held it in 1 quarter. The position peaked at $9.65K in Q1 2025. 40 funds tracked by Wall St. Rank hold BDSX as of Q2 2025.

  • Capstone Investment Advisors reported no remaining Biodesix position as of Q2 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 772 Biodesix shares in Q2 2025, an estimated $9.65K.
  • Capstone Investment Advisors first reported a position in Biodesix in Q1 2025 and held it in 1 quarter.
  • Capstone Investment Advisors's Biodesix position peaked at $9.65K in Q1 2025.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q2 2025.

Based on Capstone Investment Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.